📝 Chemiesynth (Vapi) Ltd — results explained
Quarter ended June 2026 (Q1 FY27)
Chemiesynth (Vapi) Ltd reported revenue of ₹4 crore for the quarter ended June 2026 (Q1 FY27), up 5.7% from ₹4 crore in the same quarter last year, and down 23.7% sequentially over the March 2026 quarter.
The company reported a net loss of ₹1 crore, against a net loss of ₹0 crore in the same quarter last year. Earnings per share (EPS) came in at ₹-1.90.
Operating profit stood at ₹0 crore — an operating margin (OPM) of 0.9%, compared with 4.5% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Chemiesynth (Vapi) Ltd posted revenue of ₹21 crore, a growth of 13.5% over FY25, with a net loss of ₹1 crore.
On a trailing-twelve-month (TTM) basis, revenue stands at ₹22 crore with a net loss of ₹1 crore.
Valuation snapshot
At the current price of ₹98.71, 539230 has a market capitalisation of ₹30 crore.
Within the Specialty Chemicals industry, it is the 25th-largest of the 66 companies we track by market value.
Shareholding pattern
As of Jun 2026, promoters held 62.35%, public shareholders 37.66% of Chemiesynth (Vapi) Ltd.